Diabetes Pathophysiology: Pancreas, Insulin, Glucose Homeostasis & Types
Anatomy & Physiology of Glucose Regulation
Pancreas: Dual Function
- Exocrine: Acinar cells → digestive enzymes (amylase, lipase, proteases) → duodenum.
- Endocrine: Islets of Langerhans (1–2% pancreatic mass).
- β-cells (65–80%): insulin + amylin.
- α-cells (15–20%): glucagon.
- δ-cells: somatostatin.
- PP cells: pancreatic polypeptide.
Insulin Action
- Binds receptor tyrosine kinase → IRS → PI3K/Akt → GLUT4 translocation (muscle, fat).
- Suppresses hepatic gluconeogenesis/glycogenolysis.
- Promotes lipogenesis, protein synthesis.
- Half-life ~5–6 min; pulsatile secretion.
Glucose Homeostasis Loop
- Meal → glucose ↑ → β-cell depolarization (K_ATP closure) → Ca²⁺ influx → insulin exocytosis.
- Insulin → peripheral uptake + hepatic storage → glucose ↓.
- Glucose ↓ → α-cell glucagon ↑ → hepatic output ↑.
Diabetes Classification
| Type | Pathophysiology | Key Features |
|---|---|---|
| T1DM | Autoimmune β-cell destruction (T-cell mediated) | Absolute insulin deficiency; ketoacidosis prone; HLA-DR3/DR4; GAD65, IA-2, ZnT8 Abs |
| T2DM | Insulin resistance + progressive β-cell failure | Relative deficiency; metabolic syndrome; polygenic; lifestyle-modifiable |
| GDM | Placental hormones (hPL, cortisol, progesterone) → insulin resistance | Screen 24–28 wk; ↑ future T2DM risk 7×; offspring metabolic programming |
| Other | MODY (monogenic), LADA (slow autoimmune), pancreatogenic (Type 3c), drug-induced | Specific genetic/secondary causes |
Management Pillars
- Glucose monitoring (CGM preferred).
- Medical nutrition therapy (carb consistency, fiber, healthy fats).
- Physical activity (150 min aerobic + 2× resistance).
- Pharmacotherapy: metformin first-line T2DM; insulin mandatory T1DM; GLP-1 RA, SGLT2i for cardiorenal benefit.
- Complication screening (retina, nephro, neuro, vascular).
Diabetes - Related Articles
- Rapid-Acting Insulin: Timing, Dosing, and Clinical Uses
- Metabolic Surgery for Type 2 Diabetes: A Comprehensive Overview
- The Pioneers of Insulin Pump Technology: A History
- Diabetes Research Grants & Funding Opportunities | [Your Organization Name]
- Understanding Dangerous Blood Sugar Levels: Risks & Ranges
- Understanding Medication Options for Type 2 Diabetes
- Understanding Diabetes: Symptoms, Risks & Long-Term Effects
